Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

No Influence of Peripheral Blood CD34+ and CD3+ Graft Cell Counts on Outcomes after Reduced-Intensity Conditioning Transplantation Using Post-Transplant Cyclophosphamide

Alice Garnier, MD, Thierry Guillaume, MD PhD, Pierre Peterlin, Amandine Le Bourgeois, PhD, Alix Duquesne, Marion Eveillard, PharmD, PhD, Beatrice Mahe, MD, Viviane Dubruille, MD, Nicolas Blin, MD, Cyrille Touzeau, MD PhD, Thomas Gastinne, MD, Anne Lok, MD, Antoine Bonnet, MD, Steven LE Gouill, MD PhD, Philippe Moreau, Marie C Bene, PharmSci, PhD, Patrice Chevallier, MD

Blood (2018) 132 (Supplement 1): 4577.

https://doi.org/10.1182/blood-2018-99-112453

Published: 2018

Journal Articles

Influence of Donor Type (sibling vs matched-unrelated donor vs haplo-identical donor vs cord blood) on Outcomes after Clofarabine-Based Reduced-Intensity Conditioning Allograft for Myeloid Malignancies

Louise Bouard, Thierry Guillaume, MD PhD, Pierre Peterlin, Alice Garnier, MD, Amandine Le Bourgeois, PhD, Alix Duquesne, Beatrice Mahe, MD, Viviane Dubruille, MD, Nicolas Blin, MD, Cyrille Touzeau, MD PhD, Thomas Gastinne, MD, Anne Lok, MD, Antoine Bonnet, MD, Steven LE Gouill, MD PhD, Philippe Moreau, Marie C Bene, PharmSci, PhD, Patrice Chevallier, MD

Blood (2018) 132 (Supplement 1): 3451.

https://doi.org/10.1182/blood-2018-99-112369

Published: 2018

Journal Articles

CMV Status Predicts Survival in Refractory/Relapsed Myeloid Patients after a Clofarabine-Based Sequential Regimen: A Retrospective Study on Behalf of the SFGM-TC

Amandine Le Bourgeois, PhD, Myriam Labopin, MD PhD, Felipe Suarez, MD PhD, Regis Peffault De Latour, MD PhD, Didier Blaise, Sylvain Chantepie, Stephanie Nguyen-Quoc, Natacha Maillard, MD, Reza Tabrizi, MD, Ibrahim Yakoub-Agha, Anne Huynh, MD, Tony Marchand, Karin Bilger, Patrice Ceballos, MD, Amandine Charbonnier, Pascal Turlure, MD, Mohamad Mohty, MD PhD, Patrice Chevallier, MD

Blood (2017) 130 (Supplement 1): 3217.

https://doi.org/10.1182/blood.V130.Suppl_1.3217.3217

Published: 2017

Journal Articles

NK-Cell Alloreactivity Is Associated with Acute Gvhd and Decreased Relapse Incidence after T-Replete Haplo-Identical Allotransplant with High-Dose Post-Transplant Cyclophosphamide

Christelle Retiere, Catherine Willem, Nolwenn Legrand, Thierry Guillaume, MD PhD, Katia Gagne, Pierre Peterlin, MD, Alice Garnier, MD, Marie C Bene, PharmD,DPhil, Amandine Le Bourgeois, PhD, Patrice Chevallier, MD

Blood (2017) 130 (Supplement 1): 3262.

https://doi.org/10.1182/blood.V130.Suppl_1.3262.3262

Published: 2017

Journal Articles

Impact of Early Post-Transplant 5-Point Deauville Scale (18)F-FDG-PET Status on Survival Outcomes after Allogeneic Transplantation for Lymphoma

Louise Bouard, Caroline Bodet-Milin, Thierry Guillaume, MD PhD, Pierre Peterlin, MD, Clement Bailly, Alice Garnier, MD, Amandine Le Bourgeois, PhD, Beatrice Mahe, MD, Viviane Dubruille, MD, Nicolas Blin, Pierre Gallas, MD, Cyrille Touzeau, MD PhD, Thomas Gastinne, MD, Anne Lok, MD, Lucie Planche, Steven Le Gouill, MDPhD, Philippe Moreau, MDPhD, Francoise Kraeber-Bodere, Patrice Chevallier, MD

Blood (2017) 130 (Supplement 1): 3266.

https://doi.org/10.1182/blood.V130.Suppl_1.3266.3266

Published: 2017

Journal Articles

Subcutaneous Rituximab Given to Patients for Other Indications Than CD20+ B-Cell Lymphoma: A Monocentric Study of 20 Cases

Pierre Peterlin, MD, Thierry Guillaume, MD PhD, Alice Garnier, MD, Amandine Le Bourgeois, PhD, Beatrice Mahe, MD, Viviane Dubruille, MD, Nicolas Blin, MD, Pierre Gallas, MD, Cyrille Touzeau, MD PhD, Thomas Gastinne, MD, Anne Lok, MD, Patrick Thomaré, PharmSciD, Cécile Chauvin, PharmSciD, Steven Le Gouill, MD PhD, Philippe Moreau, MDPhD, Patrice Chevallier, MD PhD

Blood (2017) 130 (Supplement 1): 5477.

https://doi.org/10.1182/blood.V130.Suppl_1.5477.5477

Published: 2017

Journal Articles

Elevated Cardiovascular Risk Factors at Time of Allotransplant Do Not Impact Survivals in Adult Patients: A Retrospective Study of 194 Cases

Sophie Vantyghem, Thierry Guillaume, MD PhD, Pierre Peterlin, MD, Alice Garnier, MD, Amandine Le Bourgeois, PhD, Beatrice Mahe, MD, Viviane Dubruille, MD, Nicolas Blin, Pierre Gallas, MD, Cyrille Touzeau, MD PhD, Thomas Gastinne, MD, Anne Lok, MD, Steven Le Gouill, MDPhD, Philippe Moreau, MDPhD, Marie C Bene, PharmD,DPhil, Patrice Chevallier, MD

Blood (2017) 130 (Supplement 1): 5533.

https://doi.org/10.1182/blood.V130.Suppl_1.5533.5533

Published: 2017

Journal Articles

Clofarabine/Busulfan-Based Reduced Intensity Conditioning Regimens Provides Very Good Survivals in Patients Allografted in Remission for Acute Myeloid Leukemia: A Retrospective Study on Behalf of the SFGM-TC

Amandine Le Bourgeois, PhD, Myriam Labopin, MD PhD, Sebastien Maury, MD PhD, Regis Peffault De Latour, MD PhD, Jean-Henri Bourhis, Patrice Ceballos, MD, Sylvie François, Karin Bilger, Didier Blaise, Thierry Guillaume, MD PhD, Mohamad Mohty, MD PhD, Patrice Chevallier, MD

Blood (2017) 130 (Supplement 1): 1952.

https://doi.org/10.1182/blood.V130.Suppl_1.1952.1952

Published: 2017

Journal Articles

Clofarabine-Based Reduced Intensity Conditioning Regimen with Post-Transplant Cyclophosphamide and Peripheral Stem Cell Graft in Adults with Myeloid Malignancies: Results of the Clo-Baltimore Regimen

Patrice Chevallier, MD, Pierre Peterlin, MD, Alice Garnier, MD, Amandine Le Bourgeois, PhD, Beatrice Mahe, MD, Viviane Dubruille, MD, Nicolas Blin, Pierre Gallas, MD, Cyrille Touzeau, MD PhD, Thomas Gastinne, MD, Anne Lok, MD, Yannick LE Bris, MDPharmD, Marie C Bene, PharmD,DPhil, Hugo Charles, Steven Le Gouill, MDPhD, Philippe Moreau, MDPhD, Thierry Guillaume, MD PhD

Blood (2017) 130 (Supplement 1): 1964.

https://doi.org/10.1182/blood.V130.Suppl_1.1964.1964

Published: 2017

Journal Articles

Mixed Chimerism of Bone Marrow CD34+ Sorted Cells after Matched or Haploidentical Allogeneic Stem Cell Transplantation for Myeloid Malignancies Is Predictive of Relapse

Yannick LE Bris, MDPharmD, Audrey Menard, Thierry Guillaume, MD PhD, Pierre Peterlin, MD, Alice Garnier, MD, Amandine Le Bourgeois, PhD, Philippe Moreau, MDPhD, Mohamad Mohty, MD PhD, Marie C Bene, PharmD,DPhil, Patrice Chevallier, MD

Blood (2017) 130 (Supplement 1): 1930.

https://doi.org/10.1182/blood.V130.Suppl_1.1930.1930

Published: 2017

NARROW

No Influence of Peripheral Blood CD34+ and CD3+ Graft Cell Counts on Outcomes after Reduced-Intensity Conditioning Transplantation Using Post-Transplant Cyclophosphamide

Influence of Donor Type (sibling vs matched-unrelated donor vs haplo-identical donor vs cord blood) on Outcomes after Clofarabine-Based Reduced-Intensity Conditioning Allograft for Myeloid Malignancies

CMV Status Predicts Survival in Refractory/Relapsed Myeloid Patients after a Clofarabine-Based Sequential Regimen: A Retrospective Study on Behalf of the SFGM-TC

NK-Cell Alloreactivity Is Associated with Acute Gvhd and Decreased Relapse Incidence after T-Replete Haplo-Identical Allotransplant with High-Dose Post-Transplant Cyclophosphamide

Impact of Early Post-Transplant 5-Point Deauville Scale (18)F-FDG-PET Status on Survival Outcomes after Allogeneic Transplantation for Lymphoma

Subcutaneous Rituximab Given to Patients for Other Indications Than CD20+ B-Cell Lymphoma: A Monocentric Study of 20 Cases

Elevated Cardiovascular Risk Factors at Time of Allotransplant Do Not Impact Survivals in Adult Patients: A Retrospective Study of 194 Cases

Clofarabine/Busulfan-Based Reduced Intensity Conditioning Regimens Provides Very Good Survivals in Patients Allografted in Remission for Acute Myeloid Leukemia: A Retrospective Study on Behalf of the SFGM-TC

Clofarabine-Based Reduced Intensity Conditioning Regimen with Post-Transplant Cyclophosphamide and Peripheral Stem Cell Graft in Adults with Myeloid Malignancies: Results of the Clo-Baltimore Regimen

Mixed Chimerism of Bone Marrow CD34+ Sorted Cells after Matched or Haploidentical Allogeneic Stem Cell Transplantation for Myeloid Malignancies Is Predictive of Relapse

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only